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Abstract
We report two genetically unrelated ethnic Chinese women, aged 63 and 60 years, who developed
Parkinson’s disease at the age of 55 and 53 years respectively. Both cases were working in the same
joss paper shop for 15 years prior to the onset of Parkinson’s disease. There was no family history of
Parkinson’s disease and exposure to other chemical or toxic agents. Biochemical analysis of joss papers
revealed the presence of heavy metals such as lead, copper, zinc, and mercury, which has been
implicated in the pathogenesis of Parkinson’s disease. The Parkinson’s disease in these two cases was
attributed to occupational exposure to joss paper. Joss paper has not been associated with the
development of Parkinson’s disease previously.
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INTRODUCTION
Joss paper is a ceremonial paper used in China
and other parts of Asia. It is burned during
religious ceremony to pay respect to the ancestors.
It consists of thin, rough, usually rice paper, often
with metallic leaf attached. There are two main
types of joss paper. The first type (Figure 1) has
metallic leaf in the centre of the page with orange
colouring that makes the metal leaf look like
gold. Printed over the leaf is a red block print
with Chinese writing and patterns. The second
type (Figure 2) has two pieces of metallic leaf on
both sides of the page. One side has the orange
colouring that makes the metal leaf look like
gold. The other side is left uncoloured so that the
leaf is silver in colour. Previously, joss paper
commonly used in Malaysia was manufactured
locally. Since 1990, with rising import from China,
the local production of joss paper had ceased.
Until today, the tradition of burning joss paper
is still widely practiced by the ethnic Chinese in
Malaysia. Despite this, there have been no
previous reports of health problems associated
with joss papers in the literature. We present two
genetically unrelated cases of Parkinson’s disease
with occupational exposure to joss paper.
CASE REPORTS
Case one and two were ethnic Chinese women,
aged 63 and 60 years respectively. Both women
were previously of good health. Case one started
to have slowly progressive right-sided stiffness
and slowness of movement in 1994, at the age of
55. Case two developed right-sided stiffness and
tremor of hand in 1996, at the age of 53. Case one
had one sibling, and Case two nine. Both had no
parental consanguinity or family history of
Parkinson’s disease.
During their first presentations, physical
examination revealed right-sided cogwheel rigidity
and  bradykinesia. Case two also had resting
tremor. Their facial expression was reduced. The
cognitive function such as memory and language
was normal. There were no other abnormal
neurological signs suggestive of parkinsonism-
plus syndromes. The following investigations were
negative: full blood count, serum urea and
electrolytes, liver function test, VDRL (Venereal
Disease Research Laboratory), serum
ceruloplasmin, copper, serum complement factors,
anti-nuclear factor, anti-double stranded DNA
antibody and chest Xray. MR imaging study of
brain in the second patient did not show any
abnormality while Case one declined MR imaging.
Both patients were started on levodopa and
had good clinical response at a total daily dose of
400 to 600 mg. They subsequently developed
peak dose dyskinesia with choreoathetosis
involving cervical and limbs muscles, wearing-
off phenomenon and early morning foot dystonia
after being treated with levodopa for eight and six
years respectively. In 2002, Case two underwent
bilateral deep brain stimulation of subthalamic
nuclei with significant symptomatic improvement,
with increased “on” period and reduction in
dyskinesia. Her total daily requirement of levodopa
was also reduced by about 60%.
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Case one and two had been working in a joss
paper shop since 1974, and were both wives of
the shop owner. Their work involved selling joss
papers and joss sticks that were supplied by local
manufacturers. Whereas the joss sticks were sealed
with plastic coverings, the joss papers were usually
sold in bundles without wrappings. There were
two other workers in the shop, but only Cases one
and two were directly handling the joss papers.
Other than the joss papers, both patients were not
exposed to other chemical or toxic agents. In
1988, they stopped working with the joss paper
when the shop closed down for economical
reasons. The other two workers remained healthy
till to date.
Samples of joss papers available at a joss
paper shop, which were imported from China
was sent for chemical analysis by the Standard
and Industrial Research Institute of Malaysia
Limited (SIRIM) laboratory. The metallic contents
of the metallic leaves of both types of joss paper,
Specimen A (Figure 1) and Specimen B (Figure
2) were analysed. The laboratory techniques used
were: Flameless Atomic Absorption Spectroscopy
for determination of mercury, and Inductively
Coupled Plasma Optical Emission Spectroscopy
for determination of arsenic, cadmium, copper,
lead, selenium, tin and zinc. As the standard
reference for the level of heavy metals in joss
papers was not available, the results of the
chemical analysis were compared with that
recommendation from the SIRIM1 as shown on
Table 1. The concentration of lead in the joss
paper Specimen A was found to exceed the
maximum level allowed by the SIRIM. Tin,
copper, zinc, arsenic, and other heavy metals
were also found in the joss papers.
DISCUSSION
We described two patients with Parkinson’s
disease who had previous occupational exposure
to joss papers. The typical neurological
presentation, good response to levodopa and
development of motor complications fulfilled the
UK Parkinson’s Disease Society Brain Bank
clinical diagnostic criteria for definite PD.2 The
levodopa-induced choreoathetosis was seen in
40% of patients after five years of  therapy.3 The
good response of the Case two to bilateral deep
brain stimulation of subthalamic nuclei, with
improvement in “on” period and dyskinesia,
reduction of total daily levodopa requirement,
was also similar to previous report.4
Parkinson’s disease is believed to be the result
of the interplay between genetic and
environmental factors, with the relative
contribution of each factor varying from one
individual to another.5 In the present case report,
genetic factor was probably not the dominant
cause of their Parkinson’s disease. Firstly, there
was no family history of overt Parkinson’s disease,
particularly in Case two, who had nine siblings.
Secondly, both cases were of late-onset PD, at 55
and 53 years. The mean age of onset of previously
reported Malaysian case series of Parkinson’s
disease was 57 years.6 It has been known that it is
the young onset Parkinson’s disease with age of
onset less than 40 years where genetic factor is
more likely to play a dominant role.7 Cases one
Table 1: Comparison of results of biochemical analysis of joss paper specimens with
Recommended safety limit from SIRIM, 1998.
              Concentration (microgram / gram)
Joss paper Joss paper Recommended safety limits of element for
Specimen A Specimen B modelling clay and finger paint
Arsenic 1.40 0.46 25.00
Cadmium 0.10 < 0.003 50.00
Copper 8.34 1.24 not available
Lead 320.81 0.58 90.00
Selenium 0.36 < 0.01 500.00
Tin 488.26 28.88 not available
Zinc 3.42 3.94 not available
Mercury 0.02 < 0.01 25.00
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and two, though both were wives of the same
man, were not genetically related.
We believe the joss papers were the critical
causative environmental factor causing the
Parkinson’s disease in our patients. Both cases
were working with joss paper for 15 years, a long
period of exposure. Among the four workers in
the same shop, both workers handling the joss
papers directly developed the disease whereas
the other two workers who did not handle joss
papers remained well. Our patients had no
exposure to other known chemical or toxic agents.
Among the heavy metals found to be present in
the joss papers analysed, lead8,9, copper8,9, zinc8,
and mercury8-10 have been implicated in the
pathogenesis of Parkinson’s disease, with lead in
excessive amount in one of the sample tested.
Iron11 and manganese8,12 were not analysed in our
patients. The substantia nigra in Parkinson’s
disease is oxidatively stressed13 and heavy metals
have been suggested to be the promoters of this
biochemical process by means of free radical
generation.14 In addition, in vitro study has shown
that heavy metals could increase the folding of a-
synuclein fibrils15, the major component of Lewy
bodies.16 Another study found that heavy metals
might act alone or together in the causation of the
PD.17 The heavy metals can be absorbed into the
body system through inhalation, oral ingestion
and skin contact.18
Due to the time delay between exposure to
heavy metals and clinical manifestation of
Parkinson’s disease, chemical screening to
confirm the excessive presence of heavy metals
in the patients was not possible. Chemical analysis
of the actual joss papers that the patients were
exposed to was also not done, as local production
of joss papers had ceased since 1990. The joss
papers analysed were those imported from China.
The metallic content of the locally manufactured
and imported joss papers may be different. Studies
of environmental risk factors for a disease with
long latency period such as Parkinson’s disease
are often difficult. This is because exposure to
certain environmental factors may occur before
the onset of clinical manifestations and remain
unrecognised.
It is also possible that there are other
unidentified environmental factors, which had
acted together with the heavy metals in joss paper
in triggering Parkinson’s disease in our patients
(“the second hit hypothesis”). The first exposure
to the putative environmental neurotoxin might
have damaged only a small proportion of
nigrostriatal neurons, leading to a decline in
dopaminergic function that was not severe enough
to be clinically manifested. The second exposure
to environmental neurotoxin (joss paper) could
have accelerated the decline in dopaminergic
function: “the second hit”, leading to the
appearance of clinical symptoms. In other words,
the joss paper exposure could have brought
forward the onset of Parkinson’s disease in these
two patients, who might have been likely to
develop the condition in any case at a later date.
It has been hypothesized that combinations of
environmental factors may result in more severe
nigrostriatal injury, leading to development of
Parkinson’s disease.19 In animal experiment, it
had been shown that in the presence of
Diethyldithiocarbamate, a normally nontoxic dose
of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) caused nigral cell loss and dopamine
depletion.20
Our two patients developed typical Parkinson’s
disease following joss paper exposure. They were
clearly different from another form of neurological
syndrome that occurred following exposure to
very high levels of heavy metal exposure. For
example, chronic manganese intoxication in
Figure 1. Joss paper Specimen A
Figure 2. Joss paper Specimen B
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welders resulted in a parkinsonian syndrome
(manganism), which differed from Parkinson’s
disease in several aspects: clearer temporal
relationship between the symptom onset and
exposure, rapid progression, levodopa
unresponsiveness, absence of reduction in
fluorodopa reuptake on Positron Emission
Tomography and possible resolution of symptoms
by stopping the exposure to the toxin.21-22
In view of the common practice of burning
joss papers among the Chinese community in
Asia, there should be greater awareness of the
potential occupational hazards of selling joss
papers. Chemical analysis for heavy metals in the
commonly used joss papers, and systematic health
survey and chemical screening of workers with
long exposure to joss paper may shed further
light on the hazards of joss papers.
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